Calidi Biotherapeutics (CLDI) Other Operating Expenses (2022 - 2025)
Calidi Biotherapeutics' quarterly Other Operating Expenses came in at -$94000.0 in Q4 2025, up 6.0% year-on-year from -$88679.2 in Q4 2024, and up 10.48% quarter-over-quarter from -$105000.0 in Q3 2025.
Calidi Biotherapeutics has reported Other Operating Expenses for 3 years, with the latest figure at -$94000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses rose 6.0% year-over-year to -$94000.0; the trailing twelve-month figure through Dec 2025 stood at -$295000.0 (up 1.67% YoY), and the FY2025 full-year result was -$386000.0, up 3.98% from the prior year.
- Other Operating Expenses for Q4 2025 stood at -$94000.0, up from -$105000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $528858.0 in Q1 2022, with the low at -$105000.0 in Q3 2025.
- Average Other Operating Expenses over 3 years is $36935.0, with a median of -$97500.0 recorded in 2024.
- Peak annual rise in Other Operating Expenses reached 6.0% in 2025, while the deepest fall reached 6.06% in 2025.
- Tracing CLDI's Other Operating Expenses over 3 years: stood at $361622.0 in 2022, then sank by 127.65% to -$100000.0 in 2024, then increased by 6.0% to -$94000.0 in 2025.
- The last three Other Operating Expenses figures came in at -$94000.0 (Q4 2025), -$105000.0 (Q3 2025), and -$96000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -94,000.00 |
| Sep 30, 2025 | -105,000.00 |
| Jun 30, 2025 | -96,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Sep 30, 2024 | -99,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Jun 30, 2022 | 361,622.00 |
| Mar 31, 2022 | 528,858.00 |